Brain-Injected gene therapy trial offers hope for rare genetic disorder
Disease control
Recruiting now
This early-stage study is testing whether a new gene therapy called MZ-1866 is safe for people with Pitt Hopkins Syndrome, a rare genetic disorder that affects brain development. Twelve children and adults will receive a single injection of the therapy directly into the fluid aro…
Phase: PHASE1, PHASE2 • Sponsor: Mahzi Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC